Abstracts tagged "diagnosis"

Abstract Number: 103 • 2012 ACR/ARHP Annual Meeting
A Pragmatic Musculoskeletal Ultrasound Screening Protocol Does Not Add to a Predictive Algorithm for Persistent Inflammatory Arthritis in a UK Early Arthritis Clinic
Arthur G. Pratt¹, Alice R. Lorenzi², Gillian Wilson², Philip N. Platt³ and John D. Isaacs¹, ¹Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, ²Musculoskeletal Directorate, Freeman Hospital, Newcastle upon Tyne, United Kingdom, ³Rheumatology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
Background/Purpose: Analyses of large clinical datasets from early arthritis cohorts permit the development of algorithms that may be used for outcome prediction in individual patients.…
Abstract Number: 2186 • 2012 ACR/ARHP Annual Meeting
Ultrasonography of Major Salivary Glands in Primary Sjögren’s syndrome
Malin V. Jonsson¹, Daniel Hammenfors², Johan G. Brun² and Roland Jonsson³, ¹Department of Clinical Dentistry - Section for Oral and Maxillofacial Radiology, University of Bergen, Bergen, Norway, ²Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, ³Broegelmann Research Laboratory, the Gade Institute, University of Bergen, Bergen, Norway
Background/Purpose: Minor salivary gland biopsy is part of the diagnostic process for primary Sjögren’s syndrome (pSS), but is not suitable for repeated follow-up. Ultrasound (US)…
Abstract Number: 104 • 2012 ACR/ARHP Annual Meeting
The Usefulness of A NEW Musculoskeletal ULTRASOUND Scoring System of the Hands and Wrist Joints (US10) for Evaluation of EARLY Rheumatoid Arthritis Patients
Karine R. Luz, Rita N.V. Furtado, Marcelo M. Pinheiro, Giovanna S. Petterle and Jamil Natour, Rheumatology Division, Universidade Federal de São Paulo, São Paulo, Brazil
Background/Purpose: Ultrasound (US) can be a useful tool for monitoring rheumatoid arthritis (RA). However, it can be time consuming when applied to too many joints…
Abstract Number: 1987 • 2012 ACR/ARHP Annual Meeting
A Comparison of Unilateral and Bilateral Hip BMD
Steven C. Schaub¹, Edward S. Leib² and Diantha Howard³, ¹Medical School, U of Vermont College of Med, Burlington, VT, ²Medicine, U of Vermont College of Med, Burlington, VT, ³Statistics, Vermont Center for Clinical and Translational Science, Burlington, VT
Background/Purpose: The utility of bilateral hip dual energy x-ray absorptiometry scanning for identifying low bone mineral density has been a cause of debate. Intraperson differences…
Abstract Number: 55 • 2012 ACR/ARHP Annual Meeting
Accuracy of Canadian Health Administrative Databases in Identifying Patients with Rheumatoid Arthritis Seen by Rheumatologists
Jessica Widdifield¹, Sasha Bernatsky², J. Michael Paterson³, Karen Tu³, Ryan Ng³, J. Carter Thorne⁴, Janet E. Pope⁵ and Claire Bombardier⁶, ¹University of Toronto, Toronto, ON, Canada, ²Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, ³Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ⁴Southlake Regional Health Centre, Newmarket, ON, Canada, ⁵Medicine/Rheumatology, St. Joseph Health Care London, University of Western Ontario, London, ON, Canada, ⁶Rheumatology, University of Toronto, Toronto, ON, Canada
Background/Purpose: In a predominantly universal single-payer health system, Canadian health administrative data are a valuable tool and increasingly used for research. Few studies have rigorously…
Abstract Number: 1908 • 2012 ACR/ARHP Annual Meeting
Multinational Evidence-Based Recommendations for Diagnosis and Management of Gout: Integrating Systematic Literature Research and Expert Opinion of a Broad Panel of Rheumatologists in the 3E Initiative
Mariano Andres¹, Francisca Sivera², Alison Kydd³, John Moi⁴, Rakhi Seth⁵, Melonie K. Sriranganathan⁶, Caroline van Durme⁷, Irene AAM van Echteld⁸, Ophir Vinik⁹, Mihir D. Wechalekar¹⁰, Daniel Aletaha¹¹, Claire Bombardier⁹, Rachelle Buchbinder¹², Loreto Carmona¹³, Christopher J. Edwards¹⁴, R. Landewe¹⁵ and Désirée van der Heijde¹⁶, ¹Seccion Reumatologia, Hospital General Universitario de Alicante, Alicante, Spain, ²Sección de Reumatología, Hospital General Universitario de Elda, Alicante, Spain, ³Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada, ⁴Royal Melbourne Hospital, Melbourne, Australia, ⁵Rheumatology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, ⁶Rheumatology, St. Mary's Hospital, Isle of Wight, United Kingdom, ⁷Maastricht University Medical Centre, Maastricht, Netherlands, ⁸Atrium Medical Center, Heerlen, Netherlands, ⁹Rheumatology, University of Toronto, Toronto, ON, Canada, ¹⁰Flinders University School of Medicine, Adelaide, Australia, ¹¹Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ¹²Monash Department of Clinical Epidemiology at Cabrini Hospital, Department of Epidemiology and Preventive Medicine, Monash University, Malvern, Victoria, Australia, ¹³Health Sciences School, Universidad Camilo José Cela, Villanueva de la Cañada, Spain, ¹⁴NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, ¹⁵Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, ¹⁶Rheumatology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: The 3e (Evidence, Expertise, Exchange) Initiative is a multinational collaboration that aims to promote evidence-based medicine in rheumatology. The 2011-12 3e Initiative aimed to…
Abstract Number: 1346 • 2012 ACR/ARHP Annual Meeting
Comparison of Three Screening Tools in Psoriatic Arthritis: The Contest Study
Laura C. Coates¹, Tariq Aslam¹, A. D. Burden², Esther Burden-Teh³, Anna R. Caperon⁴, Rino Cerio⁵, Chandra Chattopadhyay⁶, Hector Chinoy⁷, Mark J. D. Goodfield⁸, Lesley Kay⁹, Bruce W. Kirkham¹⁰, Christopher R. Lovell¹¹, Helena Marzo-Ortega¹², Neil McHugh¹³, Ruth Murphy³, Costantino Pitzalis¹⁴, NJ Reynolds¹⁵, Catherine H. Smith¹⁶, Elizabeth Stewart¹⁷, Richard B. Warren¹⁸, Hilary E. Wilson¹⁹ and Philip S. Helliwell²⁰, ¹LIMM, University of Leeds, Division of Rheumatic and Musculoskeletal Disease, LIMM, University of Leeds, Leeds, United Kingdom, ²Department of Dermatology, Western Infirmary, Dumbarton Road, United Kingdom, ³Department of Dermatology, Nottingham Independent Treatment Centre, Nottingham, United Kingdom, ⁴Division of Rheumatic and Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, ⁵CMS/CAU Cutaneous Medicine and Surgery, Bart's and The London NHS Tust, United Kingdom, ⁶Department of Rheumatology, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, United Kingdom, ⁷Rheumatic Diseases Centre, The University of Manchester, Manchester, United Kingdom, ⁸Department of Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, ⁹Department of Rheumatology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom, ¹⁰Rheum Dept/ Guys Hospital, 4th Fl Thomas Guy House, London, United Kingdom, ¹¹Department of Dermatology, Royal United Hospital, Bath, United Kingdom, ¹²Leeds Musculoskeletal Biomedical Research Unit and University of Leeds, Leeds, United Kingdom, ¹³Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, ¹⁴Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, QMUL, London, United Kingdom, ¹⁵Department of Dermatology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom, ¹⁶St John's Institute of Dermatology, Guys and St Thomas' Hospital, London, ¹⁷Department of Dermatology, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, United Kingdom, ¹⁸Dermatology Centre, University of Manchester, Manchester, United Kingdom, ¹⁹Department of Rheumatology, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom, ²⁰PsAID taskforce, EULAR, Zurich, Switzerland
Background/Purpose: The majority of patients with PsA have psoriasis prior to arthritis and there is evidence that a significant proportion of patients in dermatology clinics…
Abstract Number: 1189 • 2012 ACR/ARHP Annual Meeting
Stromal Cell Markers in the Synovial Tissue of Patients with Early Arthritis and Preclinical Rheumatoid Arthritis
Yuen Kei Choi¹, Olga N. Karpus², Paul Peter Tak³, Jörg Hamann⁴, Christopher D. Buckley⁵, Andrew Filer⁶ and Danielle M. Gerlag⁷, ¹Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, ²1Departments of Experimental Immunology and Internal Medicine, Academic Medical Center, Amsterdam, Netherlands, ³Academic Medical Center / University of Amsterdam, Department of Clinical Immunology and Rheumatology & GlaxoSmithKline, Amsterdam, Netherlands, ⁴Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, ⁵Center for Translational Inflammation Research, School of Immunity and Infection, MRC Center for Immune Regulation, Birmingham, United Kingdom, ⁶Rheumatology Research Group, MRC Centre for Immune Regulation, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom, ⁷Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands
Background/Purpose: Stromal cells in synovial tissue (ST) of patients with arthritis may have an important role in the initiation and persistence of the inflammatory infiltrate.…
Abstract Number: 977 • 2012 ACR/ARHP Annual Meeting
14-3-3 Eta Is a Novel Citrullination Target in Rheumatoid Arthritis That Enhances Diagnostic Utility in Anti-CCP Negative Patients
Walter P. Maksymowych¹, Vivian P. Bykerk², Désirée van der Heijde³, R. Landewe⁴ and Anthony Marotta⁵, ¹Department of Medicine, University of Alberta, Edmonton, AB, Canada, ²Rheumatology, Hospital for Special Surgery, New York, NY, ³Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁴Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, ⁵Augurex Life Sciences Corp, North Vancouver, BC, Canada
Background/Purpose: 14-3-3 eta is normally an intracellular protein and only in the disease state is it released into the extracellular space. We have previously presented…
Abstract Number: 948 • 2012 ACR/ARHP Annual Meeting
Antibody-Based Prediction Rules for Connective Tissue Disease: Analysis of 12,555 Patients with Antinuclear Antibody Testing
Ryo Rokutanda¹, Mitsumasa Kishimoto¹, Yasuharu Tokuda², Ken-ichi Yamaguchi¹, Hisanori Shimizu¹, Yasuhiro Suyama¹, Yuri Ohara¹, Yoichiro Haji¹, Chisun Min¹, Akira Takeda¹, Yukio Matsui³ and Masato Okada¹, ¹Division of Allergy and Rheumatology, St. Luke's International Hospital, Tokyo, Japan, ²Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan, ³Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan
Background/Purpose: Antinuclear antibody (ANA) is widely used as a screening test for connective tissue diseases (CTDs). The sensitivity of this test is high in 3…
Abstract Number: 926 • 2012 ACR/ARHP Annual Meeting
Accuracy of Canadian Health Administrative Databases in Identifying Patients with Rheumatoid Arthritis Using a Random Sample of 7500 Patients Seen in Primary Care
Jessica Widdifield¹, Claire Bombardier², Sasha Bernatsky³, J. Michael Paterson⁴, Jacqueline Young⁴, Diane Green⁴, J. Carter Thorne⁵, Noah Ivers¹, Debra Butt⁴, R. Liisa Jaakkimainen⁶, Myra Wang⁴, Vandana Ahluwalia⁷, George A. Tomlinson⁸ and Karen Tu⁴, ¹University of Toronto, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto, ON, Canada, ³Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, ⁴Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ⁵Southlake Regional Health Centre, Newmarket, ON, Canada, ⁶Preventive Med and Biostatisti, University of Toronto, Toronto, ON, Canada, ⁷William Osler Health Center, Brampton, ON, Canada, ⁸Dept of Medicine/Rheumatology, Toronto General Hospital, Toronto, ON, Canada
Background/Purpose: The use of population-based health administrative databases in rheumatology research is well established, but there are ongoing concerns about validity. To date, previous validation…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].